AU2001268000A1 - Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition - Google Patents

Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition

Info

Publication number
AU2001268000A1
AU2001268000A1 AU2001268000A AU6800001A AU2001268000A1 AU 2001268000 A1 AU2001268000 A1 AU 2001268000A1 AU 2001268000 A AU2001268000 A AU 2001268000A AU 6800001 A AU6800001 A AU 6800001A AU 2001268000 A1 AU2001268000 A1 AU 2001268000A1
Authority
AU
Australia
Prior art keywords
letrozole
bicalutamide
providing
pharmaceutical combination
aromatase inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268000A
Other languages
English (en)
Inventor
Barrington Furr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001268000A1 publication Critical patent/AU2001268000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001268000A 2000-07-05 2001-07-04 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition Abandoned AU2001268000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016426 2000-07-05
GBGB0016426.9A GB0016426D0 (en) 2000-07-05 2000-07-05 Pharmaceutical combination
PCT/SE2001/001545 WO2002002107A1 (fr) 2000-07-05 2001-07-04 Combinaison pharmaceutique de bicalutamide et de letrozole pour produire un effet anti-androgenique et une inhibition d'aromatase

Publications (1)

Publication Number Publication Date
AU2001268000A1 true AU2001268000A1 (en) 2002-01-14

Family

ID=9895013

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268000A Abandoned AU2001268000A1 (en) 2000-07-05 2001-07-04 Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition

Country Status (3)

Country Link
AU (1) AU2001268000A1 (fr)
GB (1) GB0016426D0 (fr)
WO (1) WO2002002107A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
EP0748220A4 (fr) * 1994-01-21 1997-09-10 Sepracor Inc Procedes et compositions de traitement de maladies dependantes des androgenes a l'aide de r-(-)-casodex optiquement pur
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia

Also Published As

Publication number Publication date
GB0016426D0 (en) 2000-08-23
WO2002002107A1 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
HUP0201463A3 (en) Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and their use
EP1085848A4 (fr) Inhibiteurs du facteur de transcription nf-kappa b
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
IL160065A0 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP1411959A4 (fr) Compositions de curcuminoides presentant une inhibition synergique de l'expression et/ou de l'activite de la cyclooxygenase-2
AU2337799A (en) Method and compositions for promotion of wound healing
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002235520A1 (en) Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
AU2001271163A1 (en) Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
HUP0401687A3 (en) Acylsulfonamides as inhibitors of steroid sulfatase and pharmaceutical compositions containing them
IL140324A0 (en) Inhibition of transcription factor nf-kb
AU7601400A (en) Treatment and prevention of hepatic disorders
AU5673099A (en) Inhibitors of amyloid formation
AU2001262834A1 (en) Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
AU2001268000A1 (en) Pharmaceutical combination of bicalutamide and letrozole for providing an anti-androgenic effect and aromatase inhibition
AU2001271162A1 (en) Pharmaceutical combination of an anti-androgen and letrozole for providing an anit-androgenic effect and aromatase inhibition
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2003265281A1 (en) Methods and compositions for the enhancement of wound healing
PL367028A1 (en) Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular diseas
AU2001268001A1 (en) Pharmaceutical combination of an anti-androgen and anastrozole for providing an antiandrogenic effect and aromatase inhibition